Bruker’s Acquisition of Molecubes

CMS Belgium advised Bruker on the deal. Bruker on their acquisition of Molecubes, a Belgian company producing high-end preclinical imaging PET, SPECT and CT CUBES. The...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Graftys’ Acquisition of Biologics4life

CMS Belgium advised Graftys and its shareholders on the deal. Graftys and its shareholders, a Belgian Medtech company specializing in the development and manufacturing of synthetic...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Qualitest’s Acquisition of Telexiom

CMS advised Qualitest on the deal. Oppenhoff has advised the majority shareholder of Telexiom AG. Bridgepoint’s London-based portfolio company Qualitest has acquired Telexiom, a leading IT...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Koesio’s Acquisition Of Davin

CMS Belgium, alongside Allyum, assisted the shareholders of Davin. Davin, the leading distributor in Wallonia of professional printers, video projectors and document management solutions, has been...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

ALD’s Investment In Skipr

CMS assisted ALD on the deal. Cresco acted as lead counsel to Skipr. ALD, a subsidiary of Société Générale, invested in Skipr, a Belgian mobility-as-a-service (MaaS)...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Tobii’s Acquisition Of Phasya

CMS Belgium advised Phasya on the deal. Phasya has been sold to Tobii, the world-leader in eyetracking solutions. Phasya has developed software for monitoring physiological and...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here